SPEKTRAMED - Company finances
|
EUR
|
2018
From: 2017-07-01
To: 2018-06-30
|
2019
From: 2018-07-01
To: 2019-06-30
|
2020
From: 2019-07-01
To: 2020-06-30
|
2021
From: 2020-07-01
To: 2021-06-30
|
2022
From: 2021-07-01
To: 2022-06-30
|
2023
From: 2022-07-01
To: 2023-06-30
|
2024
From: 2023-07-01
To: 2024-06-30
|
2025
From: 2024-07-01
To: 2025-06-30
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,967,216 | 3,590,887 | 2,202,483 | 4,320,115 | 3,245,790 | 6,078,949 | 4,206,709 | 4,077,030 |
| Profit before tax | 23,162 | 219,341 | -103,149 | -112,591 | 206,737 | 531,257 | 189,638 | 27,423 |
| Net profit | 16,365 | 188,000 | -103,149 | -119,197 | 171,174 | 448,611 | 157,706 | 20,733 |
| Equity | 373,958 | 561,958 | 408,809 | 289,612 | 460,786 | 679,501 | 477,207 | 397,940 |
| Liabilities | 551,329 | 560,575 | 1,121,170 | 768,604 | 1,432,903 | 1,070,873 | 1,679,386 | 631,530 |
| Non-current assets | 186,449 | 185,707 | 186,389 | 26,278 | 18,240 | 21,488 | 46,137 | 68,964 |
| Current assets | 738,838 | 936,826 | 1,343,590 | 1,031,938 | 1,875,449 | 1,728,886 | 2,110,456 | 960,506 |
| Total assets | 925,287 | 1,122,533 | 1,529,979 | 1,058,216 | 1,893,689 | 1,750,374 | 2,156,593 | 1,029,470 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,149,448 | 689,883 | 777,912 |
| Social insurance contributions | - | - | - | - | - | 119,962 | 129,167 | 121,447 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +41.8% | +82.5% | -38.7% | +96.1% | -24.9% | +87.3% | -30.8% | -3.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.8% | 16.7% | -6.7% | -11.3% | 9.0% | 25.6% | 7.3% | 2.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 4.4% | 33.5% | -25.2% | -41.2% | 37.1% | 66.0% | 33.0% | 5.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.8% | 5.2% | -4.7% | -2.8% | 5.3% | 7.4% | 3.7% | 0.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.2% | 6.1% | -4.7% | -2.6% | 6.4% | 8.7% | 4.5% | 0.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.5 | 1.0 | 2.7 | 2.7 | 3.1 | 1.6 | 3.5 | 1.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 125,567 | 212,269 | 137,655 | 357,528 | 270,483 | 499,638 | 321,533 | 335,097 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SPEKTRAMED - Social security debts
The company had no debts to Sodra
SPEKTRAMED - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-06 | 2025-06-06 | 7218.17 |
| 2025-06-05 | 2025-06-05 | 7381.2 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SPEKTRAMED, UAB (code 121292719) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In financial year 2025, the company generated revenue of €4.08M and net profit of €20.7K, corresponding to a profit margin of 0.5%. Revenue decreased by 3.1% year on year, while the broader two-year trend shows a decline from €6.08M in 2023 to €4.21M in 2024 and then €4.08M in 2025. Profitability weakened much more sharply over the same period, with net profit falling from €448.6K in 2023 to €157.7K in 2024 and €20.7K in 2025. At year-end 2025, total assets stood at €1.03M, equity at €397.9K and liabilities at €631.5K. Key ratios for 2025 indicate ROE of 5.2%, ROA of 2.0%, debt-to-equity of 1.59 and asset turnover of 3.96x. Revenue per employee was €339.8K, while profit per employee was €1.7K.